Citigroup Inc., a leading institutional financial service provider, has increased its stake in the shares of Option Care Health, Inc. by 207.9% during the fourth quarter of last year, according to recent reports filed with Securities and Exchange Commission. With 689,478 shares of the company’s stock now owned by Citigroup Inc., accounting for around 0.38% of Option Care Health’s overall worth, it is clear that the company is eyeing up the potential returns on offer from this growing healthcare provider.
Option Care Health (NASDAQ:OPCH) recently announced its quarterly earnings data, beating analysts’ consensus estimates for EPS by $0.04 with a posted result of $0.26 in Q4. Additionally, Option Care Health had a net margin of 3.94% and a return on equity (ROE) that suggests it is outperforming other companies in the same industry sector. Furthermore, the company had strong revenue figures for Q4 2022 at $1.03 billion compared to a consensus estimate of $1.02 billion.
Option Care Health specializes in home infusion services and provides patients with complex compounded solutions through its national network of full-service pharmacies; working closely with managed care organizations, third-party payers, hospitals, physicians and other referral sources to provide intravenous delivery direct to patients within their homes or other non-hospital settings.
With these statistics from Option Care Health’s impressive financial results over the past year providing such positive markers for future success in what experts consider to be a quickly growing area within the healthcare sector will continue make strategic investments an attractive option even if those investments are considered aggressive.
Considering all factors that have led to such bullish projections concerning this innovative healthcare solution provider it seems evident that investors will be looking for great rewards going forward from their investment in Option Care Health like Citigroup Inc.’s increasing stake which speaks volumes about what investors see as potential in this healthcare solution provider going forward. The question for the future is how aggressively or conservatively investors will look to gain exposure to this intriguing company.
Option Care Health sees increase in institutional investments, indicating promising future for healthcare provider
On May 16, 2023, Option Care Health, Inc. was in the news for recent changes related to its institutional positions. &Other hedge funds and other institutional investors recently raised their holdings in shares of the company, indicating a promising future for the healthcare services provider.
HighTower Advisors LLC raised its holdings by 3.3% in the fourth quarter, owning 306,155 shares of the company’s stock worth $9,196,000 after purchasing an additional 9,702 shares in the last quarter. Meanwhile, UBS Group AG also upped its holdings by an impressive 83.2%, now owning 78,191 shares of the company’s stock worth $2,353,000 after buying an additional 35,501 shares in the same period.
Alliance Wealth Advisors LLC UT bought a new stake in shares of Option Care Health in the fourth quarter valued at approximately $250,000. Cambridge Investment Research Advisors Inc. also raised its holdings by 19.6% owning over 10k shares (worth around $312k). Finally, Van ECK Associates Corp raised its holdings by almost 40% owning over eight-thousand nine-hundred sixteen shares (worth about $268k).
These moves to increase institutional investment show confidence from major players within the industry that Option Care Health has a bright future ahead.
Currently trading at $26.84 a share as of Tuesday May 16th with a market capitalization of $4.82 billion and a relatively high PE ratio of 30.85 and PEG ratio of 2.03 placing it onto many investor’s radar.
Option Care Health is an engaged healthcare provider offering home and alternate site infusion services with national full-service pharmacies delivery capabilities across America and serve patients via secure solutions both in nonhospital-based settings or transition from acute care settings back into their homes or residence.
Jefferies Financial Group began coverage on shares of Option Care Health in a recent report on Monday, February 27th rating the stock as a “buy” indicating potential investors already saw potential for growth. Additionally, Barrington Research have been bullish on Option Care Health in the past but has cut their price target from $38 to $34 while Deutsche Bank Aktiengesellschaft dropped their price target further down to $32.50 demonstrating an unusual contrast.
While these companies fluctuate over time, experts have predicted continued growth in the healthcare services provider sector over the next several years. It will be interesting to see how Option Care Health performs against competitors and what changes it makes in response to new market trends. Insiders own 0.38% of the company’s stock and Executive Vice President and COO Michael Bavaro sold 6,148 shares for a total value of $193,354.60 back in March after the price had reached around $31.45 a share.
Source: beststocks.com
